Compounds > 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate
Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and carbamazepine

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with carbamazepine in 1 studies

Compound Research Comparison

Studies
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Trials
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Recent Studies (post-2010)
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Studies
(carbamazepine)		Trials
(carbamazepine)		Recent Studies (post-2010) (carbamazepine)
190011,9921,1283,101

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morimoto, K; Sato, H; Sato, K; Sato, S; Yamada, N1

Other Studies

1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and carbamazepine

ArticleYear
BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.
    European journal of pharmacology, 1997, Nov-19, Volume: 339, Issue:1

    Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Kindling, Neurologic; Male; Neuroprotective Agents; Phenytoin; Pyrimidines; Rats; Rats, Sprague-Dawley; Seizures

1997